Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts Meeting Abstract
| Authors: | Iwata, H.; Tamura, K.; Doi, T.; Tsurutani, J.; Modi, S.; Park, H.; Krop, I. E.; Sagara, Y.; Redfern, C. H.; Murthy, R. K.; Redman, R. A.; Shitara, K.; Fujisaki, Y.; Sugihara, M.; Zhang, L.; Shahidi, J.; Yver, A.; Takahashi, S. |
| Abstract Title: | Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 106s |
| Language: | English |
| ACCESSION: | WOS:000442916001281 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.2501 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2501 -- Source: Wos |
